Four novel connexin 32 mutations in X-linked Charcot–Marie–Tooth disease. Phenotypic variability and central nervous system involvement

Reilly, 2011, Charcot–Marie–Tooth disease, J Peripher Nerv Syst, 16, 1, 10.1111/j.1529-8027.2011.00324.x Abrams, 2001, Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot–Marie–Tooth disease, Brain Res, 900, 9, 10.1016/S0006-8993(00)03327-8 Bergoffen, 1993, Connexin mutations in X-linked Charcot–Marie–Tooth disease, Science, 262, 2039, 10.1126/science.8266101 Stronach, 1999, Novel PCR-based diagnostic tools for Charcot–Marie–Tooth type 1A and hereditary neuropathy with liability to pressure palsies, J Peripher Nerv Syst, 4, 117 Brozková, 2010, Six new gap junction beta 1 gene mutations and their phenotypic expression in Czech patients with Charcot–Marie–Tooth disease, Genet Test Mol Biomark, 14, 3, 10.1089/gtmb.2009.0093 Kleopa, 2012, How do mutations in GJB1 cause X-linked Charcot–Marie–Tooth disease?, Brain Res, 1487, 198, 10.1016/j.brainres.2012.03.068 Weber, 2004, The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities, Biophys J, 87, 958, 10.1529/biophysj.103.036350 Bone, 1997, Connexin32 and X-linked Charcot–Marie–Tooth disease, Neurobiol Dis, 4, 221, 10.1006/nbdi.1997.0152 Bort, 1997, Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot–Marie–Tooth disease and hereditary neuropathy with liability to pressure palsies, Hum Genet, 99, 746, 10.1007/s004390050442 Sorour, 1998, Mutation analysis in Charcot–Marie–Tooth disease type 1 (CMT1), Hum Mutat Suppl, 1, S242, 10.1002/humu.1380110178 Young, 2001, Mutation analysis in Chariot–Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity, J Neurol, 248, 410, 10.1007/s004150170183 Scherer, 2012, X-linked Charcot–Marie–Tooth disease, J Peripher Nerv Syst Suppl, 3, 9, 10.1111/j.1529-8027.2012.00424.x Panas, 1998, Central nervous system involvement in four patients with Charcot–Marie–Tooth disease with connexin 32 extracellular mutations, J Neurol Neurosurg Psychiatry, 65, 947, 10.1136/jnnp.65.6.947a Kassubek, 2005, Corticospinal tract MRI hyperintensity in X-linked Charcot–Marie–Tooth disease, J Clin Neurosci, 12, 588, 10.1016/j.jocn.2004.07.020 Mazzeo, 2008, Charcot–Marie–Tooth type X: unusual phenotype of a novel CX32 mutation, Eur J Neurol, 15, 1140, 10.1111/j.1468-1331.2008.02263.x Paulson, 2002, Transient central nervous system white matter abnormality in X-linked Charcot–Marie–Tooth disease, Ann Neurol, 52, 429, 10.1002/ana.10305 Senderek, 1999, X-linked dominant Charcot–Marie–Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations, J Neurol Sci, 167, 90, 10.1016/S0022-510X(99)00146-X